Open AccessViral hepatitis prevalence in patients with active and latent tuberculosis
Author(s) -
Hesam Ahmadi Nooredinvand,
David Connell,
M Asgheddi,
Mohammed Ba Abdullah,
M O’Donoghue,
Louise Campbell,
Melissa Wickremasinghe,
Ajit Lalvani,
Onn Min Kon,
Shahid A. Khan
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i29.8920
Subject(s) - medicine , hbsag , tuberculosis , immunology , hepatitis b virus , hepatitis b , liver disease , hbcag , serology , liver function , latent tuberculosis , antibody , gastroenterology , virology , virus , mycobacterium tuberculosis , pathology
To assess the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and association with drug induced liver injury (DILI) in patients undergoing anti-tuberculosis (TB) therapy.